The subgroup analysis based on source of controls also suggested that the GSTM1 null genotype was associated with laryngeal cancer risk in the population-based studies, which supported the association between GSTM1 polymorphism and laryngeal cancer risk. Here, GSTM1 is linked to laryngeal carcinoma.